NASDAQ:ALGN - Align Technology Stock Price, Forecast & News

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) announced its earnings results on Wednesday, October, 23rd. The medical equipment provider reported $1.28 EPS for the quarter, topping the consensus estimate of $1.14 by $0.14. The medical equipment provider had revenue of $607.30 million for the quarter, compared to the consensus estimate of $595.29 million. Align Technology had a net margin of 18.28% and a return on equity of 28.76%. The business's quarterly revenue was up 20.2% on a year-over-year basis. During the same period last year, the company posted $1.24 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Align Technology.

Align Technology issued an update on its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided EPS guidance of $1.35-$1.42 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.35. The company issued revenue guidance of $640-$650 million, compared to the consensus revenue estimate of $640.31 million.

12 brokers have issued 12 month price objectives for Align Technology's stock. Their forecasts range from $200.00 to $320.00. On average, they anticipate Align Technology's stock price to reach $252.82 in the next year. This suggests that the stock has a possible downside of 8.1%. View Analyst Price Targets for Align Technology.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

News articles about ALGN stock have trended negative on Wednesday, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Align Technology earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the stock's share price in the next few days. View News Stories for Align Technology.

Some companies that are related to Align Technology include Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Align Technology's stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (3.90%), Disciplined Growth Investors Inc. MN (1.18%), Fisher Asset Management LLC (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.40%), Select Equity Group L.P. (0.35%) and Worldquant Millennium Advisors LLC (0.29%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Russell Investments Group Ltd., Eagle Asset Management Inc., Carillon Tower Advisers Inc., Retirement Systems of Alabama, Parametric Portfolio Associates LLC, Banco Santander S.A. and Kornitzer Capital Management Inc. KS. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was acquired by a variety of institutional investors in the last quarter, including Select Equity Group L.P., Factory Mutual Insurance Co., Fisher Asset Management LLC, State of New Jersey Common Pension Fund D, California Public Employees Retirement System, SG Americas Securities LLC, Zurcher Kantonalbank Zurich Cantonalbank and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $275.23.

Align Technology has a market capitalization of $21.69 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]